• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by LCNB Corporation

    7/30/21 11:37:59 AM ET
    $LCNB
    Major Banks
    Finance
    Get the next $LCNB alert in real time by email
    SC 13D 1 d594815dsc13d.htm SC 13D SC 13D

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    RULE 13d-2(a)

    (Amendment No.     )

     

     

    LCNB Corp.

    (Name of Issuer)

     

     

    Common Stock, no par value

    (Title of Class of Securities)

    50181P100

    (CUSIP Number)

    John C. Lame

    8805 Tamiami Trail N. #128

    Naples, FL 34108

    Telephone: (513) 235-6982

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    July 21, 2021

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

     

     

    NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 50181P100      

     

      1    

      NAME OF REPORTING PERSONS

      I.R.S. Identification Nos. of above persons (entities only).

     

      John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS

     

      PF

      5  

      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Florida

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

     

         7     

      SOLE VOTING POWER

     

         8   

      SHARED VOTING POWER

     

      559,880 (1)

         9   

      SOLE DISPOSITIVE POWER

     

       10   

      SHARED DISPOSITIVE POWER

     

      559,880 (1)

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      559,880

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      4.43% (2)

    14  

      TYPE OF REPORTING PERSON

     

      OO

     

    (1)

    559,880 shares of common stock owned by the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018, a Florida trust, of which John C. Lame and Susan K. Lame serve as joint trustees and share voting and dispositive power with regard to the shares held by the trust.

    (2)

    Based upon 12,634,845 shares outstanding as of June 30, 2021, according to the information contained in the Issuer’s current report on Form 8-K, filed with the Securities and Exchange Commission on July 21, 2021.

     

    2


    CUSIP No. 50181P100      

     

      1    

      NAME OF REPORTING PERSONS

      I.R.S. Identification Nos. of above persons (entities only).

     

      John C. Lame IRA

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS

     

      PF

      5  

      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Florida

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

     

         7     

      SOLE VOTING POWER

     

      55,000 (1)

         8   

      SHARED VOTING POWER

     

         9   

      SOLE DISPOSITIVE POWER

     

      55,000 (1)

       10   

      SHARED DISPOSITIVE POWER

     

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      55,000 (1)

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      .44% (2)

    14  

      TYPE OF REPORTING PERSON

     

      OO

     

    (1)

    John C. Lame is the trustee of the John C. Lame IRA and in such capacity has the right to vote and dispose of the securities held by the IRA.

    (2)

    Based upon 12,634,845 shares outstanding as of June 30, 2021, according to the information contained in the Issuer’s current report on Form 8-K, filed with the Securities and Exchange Commission on July 21, 2021.

     

    3


    CUSIP No. 50181P100      

     

      1    

      NAME OF REPORTING PERSONS

      I.R.S. Identification Nos. of above persons (entities only).

     

      John C. Lame Roth Contributory IRA

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS

     

      PF

      5  

      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Florida

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

     

         7     

      SOLE VOTING POWER

     

      33,520 (1)

         8   

      SHARED VOTING POWER

     

         9   

      SOLE DISPOSITIVE POWER

     

      33,520 (1)

       10   

      SHARED DISPOSITIVE POWER

     

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      33,520 (1)

    12  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      .27% (2)

    14  

      TYPE OF REPORTING PERSON

     

      IN

     

    (1)

    John C. Lame is the trustee of the John C. Lame Roth Contributory IRA and in such capacity has the right to vote and dispose of the securities held by the IRA.

    (2)

    Based upon 12,634,845 shares outstanding as of June 30, 2021, according to the information contained in the Issuer’s current report on Form 8-K, filed with the Securities and Exchange Commission on July 21, 2021.

     

    4


    CUSIP No. 50181P100      

     

    Item 1. Security and Issuer

    This Schedule 13D relates to shares of common stock, without par value, of LCNB Corp., an Ohio corporation (the “Issuer”). The Issuer’s principal executive office is located at 2 North Broadway, Lebanon, Ohio 45036.

    Item 2. Identity and Background

    This Schedule 13D is jointly filed by John C. Lame and Susan K. Lame, Mr. Lame’s spouse, in their capacities as co-trustees of the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018 (the “Trust”); the John C. Lame IRA (the “IRA”); and the John C. Lame Roth Contributory IRA (the “Roth IRA,” and collectively, the “Reporting Persons”).

    Mr. Lame is a citizen of the United States and his present principal occupation is Chief Executive Officer of Untapped, LLC, a limited liability company. The principal business of Untapped, LLC is life guidance and wealth coaching.

    Ms. Lame is a citizen of the United States and her present principal occupation is special projects manager, Untapped, L.L.C. The principal business of Untapped, LLC is life guidance and wealth coaching.

    The Trust is an irrevocable trust established by John C. Lame and Susan K. Lame for estate planning purposes. The IRA and Roth IRA are retirement accounts established by Mr. Lame.

    The address of each Reporting Person for purposes of this filing is: 8800 Tamiami Trail N. #128, Naples, Florida 34108.

    By virtue of these relationships and pursuant to the SEC’s beneficial ownership rules, the Reporting Persons may be deemed to be members of a group.

    The Reporting Persons have not, during the past five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws.

    Item 3. Source and Amount of Funds or Other Consideration

    The Trust purchased shares of the Issuer’s common stock using Trust funds. Shares of the Issuer’s common stock held directly by the Trust, IRA and Roth IRA were acquired directly by these reporting persons. No part of the purchase price is represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the securities. Shares of the Issuer are listed on the Nasdaq Capital Market under the symbol “LCNB”.

    Item 4. Purpose of the Transaction

    The Shares covered by this Schedule 13D were acquired for investment purposes in the ordinary course of business. The Reporting Persons purchased shares based on their belief that the value of the Issuer is in excess of the current market price. The Reporting Persons’ investment objective is to profit from appreciation in the market price of the Issuer’s common stock. Mr. Lame intends to discuss the Issuer’s returns for shareholders and the Issuer’s strategy for the creation of shareholder value with management, the Issuer’s board of directors, and other shareholders of the Issuer. Mr. Lame has requested representation on the Board of Directors. Although the Reporting Persons have no other specific plan or proposal that relates to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, consistent with their investment purpose, the Reporting Persons at any time and from time to time may acquire additional shares of Common Stock or dispose of any or all of the shares of Common Stock depending upon an ongoing evaluation of the investment in the Common Stock, prevailing market conditions, other investment opportunities, liquidity requirements of the Reporting Person, and/or other investment considerations.

     

    5


    CUSIP No. 50181P100      

     

    Item 5. Interest in Securities of the Issuer

    (a) – (b) According to the Issuer’s current report on Form 8-K, filed with the Securities and Exchange Commission (“SEC”) on July 21, 2021, there were 12,634,845 shares of the Issuer’s common stock outstanding on June 30, 2021.

    The following list sets forth the aggregate number and percentage of outstanding shares of the Issuer’s common stock owned beneficially by each Reporting Person:

     

    Name

       No. of Shares     Percent of Class  

    John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018

         559,880 (1)      4.43 % 

    John C. Lame IRA

         55,000 (2)      .44 % 

    John C. Lame Contributory Roth IRA

         33,520 (2)      .27 % 

    TOTAL

         648,400       5.13 % 

     

    (1)

    John C. Lame and Susan K. Lame are joint trustees and have shared investment and voting authority with respect to these shares.

    (2)

    John C. Lame has sole investment and voting authority with respect to these shares.

    (c) The Reporting Persons’ transactions in the Issuer’s common stock in the past 60 days consist of the following purchases.

    The following open-market transactions were effected by the Trust during the past sixty (60) days:

     

    Trust  

    Trade Date

       Buy/Sell    Number of Shares      Price Per Share  

    6/18/2021

       Buy      2700      $ 16.59  

    6/18/2021

       Buy      30      $ 16.58  

    6/18/2021

       Buy      100      $ 16.57  

    6/18/2021

       Buy      1000      $ 16.55  

    6/17/2021

       Buy      1000      $ 17.08  

    6/17/2021

       Buy      1047      $ 17.05  

    6/17/2021

       Buy      500      $ 17.05  

    6/17/2021

       Buy      223      $ 17.05  

    6/17/2021

       Buy      200      $ 17.03  

    6/17/2021

       Buy      30      $ 17.02  

    6/17/2021

       Buy      504      $ 17.00  

     

    6


    CUSIP No. 50181P100      

     

    Trust  

    Trade Date

       Buy/Sell    Number of Shares      Price Per Share  

    6/17/2021

       Buy      453      $ 17.03  

    6/17/2021

       Buy      33      $ 17.02  

    6/17/2021

       Buy      10      $ 17.02  

    6/17/2021

       Buy      1000      $ 17.03  

    6/17/2021

       Buy      1000      $ 17.01  

    6/16/2021

       Buy      1000      $ 17.08  

    6/16/2021

       Buy      1000      $ 17.06  

    6/16/2021

       Buy      1000      $ 17.08  

    6/16/2021

       Buy      900      $ 17.07  

    6/16/2021

       Buy      100      $ 17.08  

    6/16/2021

       Buy      1000      $ 17.08  

    6/9/2021

       Buy      850      $ 17.34  

    6/9/2021

       Buy      1531      $ 17.34  

    6/9/2021

       Buy      36      $ 17.39  

    6/9/2021

       Buy      56      $ 17.38  

    6/9/2021

       Buy      5      $ 17.37  

    6/9/2021

       Buy      72      $ 17.37  

    6/9/2021

       Buy      200      $ 17.36  

    6/9/2021

       Buy      100      $ 17.36  

    6/9/2021

       Buy      1000      $ 17.38  

    6/9/2021

       Buy      616      $ 17.37  

    6/9/2021

       Buy      85      $ 17.36  

    6/9/2021

       Buy      99      $ 17.36  

    6/9/2021

       Buy      90      $ 17.36  

    6/9/2021

       Buy      10      $ 17.36  

    6/9/2021

       Buy      100      $ 17.36  

    The following open-market transactions were effected by the John Lame IRA during the past sixty (60) days:

     

    John IRA  

    Trade Date

       Buy/Sell    Number of Shares      Price Per Share  

    6/16/2021

       Buy      300      $ 17.06  

    6/16/2021

       Buy      300      $ 17.09  

     

    7


    CUSIP No. 50181P100      

     

    The following open-market transactions were effected by the John Lame Contributory Roth IRA during the past sixty (60) days:

     

    John C. Lame Contributory Roth IRA  

    Trade Date

       Buy/Sell    Number of Shares      Price Per Share  

    6/16/2021

       Buy      170      $ 17.06  

    6/16/2021

       Buy      100      $ 17.06  

    6/16/2021

       Buy      100      $ 17.06  

    (d) No one other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends or proceeds of sale of the shares.

    (e) not applicable

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

    Other than as described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

    Item 7. Material to Be Filed as Exhibits

     

    Exhibit
    Number

      

    Description

    99.1    Joint Filing Agreement among John C. Lame IRA, John C. Lame Roth Contributory IRA and John C. Lame and Susan K. Lame as trustees of the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May  18, 2018.

     

    8


    CUSIP No. 50181P100      

     

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: July 30, 2021

     

    John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018
    By:  

    /s/ John C. Lame

      John C. Lame, Co-Trustee
    By:  

    /s/ Susan K. Lame

      Susan K. Lame, Co-Trustee
    John C. Lame IRA
    By:  

    /s/ John C. Lame

      John C. Lame
    John C. Lame Roth Contributory IRA
    By:  

    /s/ John C. Lame

      John C. Lame

     

    9

    Get the next $LCNB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LCNB

    DatePrice TargetRatingAnalyst
    12/20/2024$16.25Market Perform
    Hovde Group
    11/30/2022$19.00Neutral
    Janney
    More analyst ratings